阿克曼西亚
肠道菌群
炎症
脂多糖
TLR4型
肠道通透性
拟杆菌
微生物学
化学
药理学
内科学
内分泌学
生物
免疫学
细菌
医学
遗传学
作者
Baoming Tian,Jianhua Zhao,Min Zhang,Zhifei Chen,Qingyu Ma,Huicui Liu,Chenxi Nie,Ziqi Zhang,Wei An,Juxiu Li
标识
DOI:10.1002/mnfr.202000745
摘要
Scope Gut barrier dysfunction and inflammation originating from a dysbiotic gut microbiota (GM) are strongly associated with a high‐fat diet (HFD). Anthocyanins from Lycium ruthenicum (ACs) show antiobesity effects through modulating the GM. However, the mechanism linking the antiobesity effects of ACs and GM modulation remains obscure. Methods and results To investigate the ameliorative effects of ACs on colonic barrier dysfunction and inflammation, mice are fed an HFD with or without ACs at doses of 50, 100, and 200 mg kg −1 for 12 weeks. AC supplementation reduced weight gain, enriched short‐chain fatty acid (SCFA)‐producing bacteria (e.g., Ruminococcaceae, Muribaculaceae, Akkermansia, Ruminococcaceae_ UCG‐014 , and Bacteroides ) and SCFA content, depleted endotoxin‐producing bacteria (e.g., Helicobacter and Desulfovibrionaceae), and decreased endotoxin (i.e., lipopolysaccharide) levels. SCFAs substantially activated G protein‐coupled receptors (GPRs), inhibited histone deacetylases (HDAC), increased intestinal tight junction mRNA and protein expression levels, reduced intestinal permeability, and protected intestinal barrier integrity in HFD‐induced mice. These effects mitigate intestinal inflammation by inhibiting the LPS/NF‐κB/TLR4 pathway. Conclusion These data indicates that ACs can mitigate colonic barrier dysfunction and inflammation, induce SCFA production and inhibit endotoxin production by modulating the GM in HFD‐fed mice. This finding provides a clue for understanding the antiobesity effects of ACs.
科研通智能强力驱动
Strongly Powered by AbleSci AI